ECOVYST INC (ECVT) Stock Fundamental Analysis
NYSE:ECVT - US27923Q1094 - Common Stock
8.97 USD
-0.04 (-0.44%)
Taking everything into account, ECVT scores 4 out of 10 in our fundamental rating. ECVT was compared to 83 industry peers in the Chemicals industry. There are concerns on the financial health of ECVT while its profitability can be described as average. ECVT has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ECVT was profitable.
ECVT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ECVT reported negative net income in multiple years.
Each year in the past 5 years ECVT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ECVT (-0.77%) is worse than 61.45% of its industry peers.
ECVT has a Return On Equity of -1.99%. This is comparable to the rest of the industry: ECVT outperforms 43.37% of its industry peers.
With a Return On Invested Capital value of 4.44%, ECVT perfoms like the industry average, outperforming 55.42% of the companies in the same industry.
ECVT had an Average Return On Invested Capital over the past 3 years of 5.69%. This is in line with the industry average of 6.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.77% | ||
| ROE | -1.99% | ||
| ROIC | 4.44% |
ROA(3y)2.47%
ROA(5y)-1.71%
ROE(3y)6.52%
ROE(5y)-4.23%
ROIC(3y)5.69%
ROIC(5y)4.4%
1.3 Margins
ECVT has a Operating Margin of 11.85%. This is in the better half of the industry: ECVT outperforms 63.86% of its industry peers.
ECVT's Operating Margin has improved in the last couple of years.
ECVT has a Gross Margin of 25.43%. This is comparable to the rest of the industry: ECVT outperforms 49.40% of its industry peers.
ECVT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.85% | ||
| PM (TTM) | N/A | ||
| GM | 25.43% |
OM growth 3Y11.88%
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-1.84%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ECVT is destroying value.
Compared to 1 year ago, ECVT has more shares outstanding
Compared to 5 years ago, ECVT has less shares outstanding
Compared to 1 year ago, ECVT has a worse debt to assets ratio.
2.2 Solvency
ECVT has an Altman-Z score of 1.08. This is a bad value and indicates that ECVT is not financially healthy and even has some risk of bankruptcy.
ECVT has a worse Altman-Z score (1.08) than 77.11% of its industry peers.
The Debt to FCF ratio of ECVT is 13.20, which is on the high side as it means it would take ECVT, 13.20 years of fcf income to pay off all of its debts.
ECVT's Debt to FCF ratio of 13.20 is in line compared to the rest of the industry. ECVT outperforms 55.42% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that ECVT has dependencies on debt financing.
ECVT's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. ECVT is outperformed by 71.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 13.2 | ||
| Altman-Z | 1.08 |
ROIC/WACC0.5
WACC8.95%
2.3 Liquidity
ECVT has a Current Ratio of 2.25. This indicates that ECVT is financially healthy and has no problem in meeting its short term obligations.
ECVT's Current ratio of 2.25 is fine compared to the rest of the industry. ECVT outperforms 61.45% of its industry peers.
A Quick Ratio of 1.69 indicates that ECVT should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.69, ECVT is doing good in the industry, outperforming 69.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
The earnings per share for ECVT have decreased by -3.51% in the last year.
Measured over the past years, ECVT shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.01% on average per year.
ECVT shows a small growth in Revenue. In the last year, the Revenue has grown by 4.93%.
Measured over the past years, ECVT shows a small growth in Revenue. The Revenue has been growing by 5.75% on average per year.
EPS 1Y (TTM)-3.51%
EPS 3Y4.38%
EPS 5Y-9.01%
EPS Q2Q%0%
Revenue 1Y (TTM)4.93%
Revenue growth 3Y4.85%
Revenue growth 5Y5.75%
Sales Q2Q%9.46%
3.2 Future
Based on estimates for the next years, ECVT will show a very strong growth in Earnings Per Share. The EPS will grow by 26.77% on average per year.
The Revenue is expected to grow by 7.36% on average over the next years.
EPS Next Y13.17%
EPS Next 2Y25.46%
EPS Next 3Y26.77%
EPS Next 5YN/A
Revenue Next Year12.59%
Revenue Next 2Y9.3%
Revenue Next 3Y7.36%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ECVT is valuated correctly with a Price/Earnings ratio of 16.31.
66.27% of the companies in the same industry are more expensive than ECVT, based on the Price/Earnings ratio.
ECVT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.03.
With a Price/Forward Earnings ratio of 9.83, the valuation of ECVT can be described as very reasonable.
ECVT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ECVT is cheaper than 85.54% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ECVT to the average of the S&P500 Index (22.63), we can say ECVT is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.31 | ||
| Fwd PE | 9.83 |
4.2 Price Multiples
ECVT's Enterprise Value to EBITDA is on the same level as the industry average.
77.11% of the companies in the same industry are more expensive than ECVT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.82 | ||
| EV/EBITDA | 10.18 |
4.3 Compensation for Growth
ECVT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ECVT's earnings are expected to grow with 26.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.24
PEG (5Y)N/A
EPS Next 2Y25.46%
EPS Next 3Y26.77%
5. Dividend
5.1 Amount
No dividends for ECVT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:ECVT (9/5/2025, 1:47:34 PM)
8.97
-0.04 (-0.44%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners93.32%
Inst Owner Change11.13%
Ins Owners1.44%
Ins Owner Change0%
Market Cap1.03B
Analysts85
Price Target10.2 (13.71%)
Short Float %3.54%
Short Ratio2.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)74.49%
Min EPS beat(2)20.26%
Max EPS beat(2)128.72%
EPS beat(4)3
Avg EPS beat(4)36.73%
Min EPS beat(4)-17.17%
Max EPS beat(4)128.72%
EPS beat(8)3
Avg EPS beat(8)12.26%
EPS beat(12)6
Avg EPS beat(12)9.79%
EPS beat(16)10
Avg EPS beat(16)11.07%
Revenue beat(2)0
Avg Revenue beat(2)-4.48%
Min Revenue beat(2)-5.69%
Max Revenue beat(2)-3.26%
Revenue beat(4)0
Avg Revenue beat(4)-5.5%
Min Revenue beat(4)-7.53%
Max Revenue beat(4)-3.26%
Revenue beat(8)0
Avg Revenue beat(8)-4.98%
Revenue beat(12)1
Avg Revenue beat(12)-4.48%
Revenue beat(16)5
Avg Revenue beat(16)-1.77%
PT rev (1m)0%
PT rev (3m)4.48%
EPS NQ rev (1m)-31.59%
EPS NQ rev (3m)-15.56%
EPS NY rev (1m)2.31%
EPS NY rev (3m)5.67%
Revenue NQ rev (1m)1.31%
Revenue NQ rev (3m)10.58%
Revenue NY rev (1m)0.95%
Revenue NY rev (3m)1.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.31 | ||
| Fwd PE | 9.83 | ||
| P/S | 1.42 | ||
| P/FCF | 15.82 | ||
| P/OCF | 7 | ||
| P/B | 1.48 | ||
| P/tB | 5.38 | ||
| EV/EBITDA | 10.18 |
EPS(TTM)0.55
EY6.13%
EPS(NY)0.91
Fwd EY10.18%
FCF(TTM)0.57
FCFY6.32%
OCF(TTM)1.28
OCFY14.3%
SpS6.32
BVpS6.05
TBVpS1.67
PEG (NY)1.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.77% | ||
| ROE | -1.99% | ||
| ROCE | 5.11% | ||
| ROIC | 4.44% | ||
| ROICexc | 4.63% | ||
| ROICexgc | 6.73% | ||
| OM | 11.85% | ||
| PM (TTM) | N/A | ||
| GM | 25.43% | ||
| FCFM | 8.97% |
ROA(3y)2.47%
ROA(5y)-1.71%
ROE(3y)6.52%
ROE(5y)-4.23%
ROIC(3y)5.69%
ROIC(5y)4.4%
ROICexc(3y)6.1%
ROICexc(5y)4.71%
ROICexgc(3y)9.02%
ROICexgc(5y)6.89%
ROCE(3y)6.55%
ROCE(5y)5.06%
ROICexcg growth 3Y19.33%
ROICexcg growth 5Y28.08%
ROICexc growth 3Y19.89%
ROICexc growth 5Y30.34%
OM growth 3Y11.88%
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-1.84%
F-Score4
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 13.2 | ||
| Debt/EBITDA | 4.75 | ||
| Cap/Depr | 88.11% | ||
| Cap/Sales | 11.31% | ||
| Interest Coverage | 2.19 | ||
| Cash Conversion | 82.15% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 1.08 |
F-Score4
WACC8.95%
ROIC/WACC0.5
Cap/Depr(3y)76.28%
Cap/Depr(5y)73.6%
Cap/Sales(3y)8.81%
Cap/Sales(5y)11.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.51%
EPS 3Y4.38%
EPS 5Y-9.01%
EPS Q2Q%0%
EPS Next Y13.17%
EPS Next 2Y25.46%
EPS Next 3Y26.77%
EPS Next 5YN/A
Revenue 1Y (TTM)4.93%
Revenue growth 3Y4.85%
Revenue growth 5Y5.75%
Sales Q2Q%9.46%
Revenue Next Year12.59%
Revenue Next 2Y9.3%
Revenue Next 3Y7.36%
Revenue Next 5YN/A
EBIT growth 1Y-14.53%
EBIT growth 3Y17.3%
EBIT growth 5Y7.72%
EBIT Next Year81.32%
EBIT Next 3Y28.82%
EBIT Next 5YN/A
FCF growth 1Y-36.69%
FCF growth 3Y5.01%
FCF growth 5Y-10.41%
OCF growth 1Y-16.06%
OCF growth 3Y4.89%
OCF growth 5Y-10.96%